Related Experiment Video
Updated: May 4, 2026

14:24
Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
10.8K
The Year in Cardiology 2013: heart failure
1Medizinische Klinik 1/Deutsches Zentrum für Herzinsuffizienz, Würzburg, Germany.
European Heart Journal
|January 4, 2014
Summary
Heart failure is a global epidemic. Advances in genetics, proteomics, and cell therapy offer hope for improved diagnostics and individualized treatments for heart failure patients.
Area of Science:
- Cardiology
- Biomedical Science
Background:
- Heart failure presents a growing worldwide epidemic, significantly impacting healthcare.
- Current therapeutic strategies are guided by the 2012 ESC and 2013 ACCF/AHA guidelines, aiming to reduce mortality and morbidity.
Purpose of the Study:
- To review recent advancements and future directions in heart failure management.
- To highlight emerging therapeutic avenues for acute and diastolic heart failure.
Main Methods:
- Review of current guidelines and emerging research in cardiology.
- Analysis of progress in genetics, proteomics, and cell-based therapies.
Main Results:
- Identification of patient subgroups benefiting from mitral reconstruction and heart failure management programs.
- Progress in understanding the genetic and proteomic underpinnings of heart failure.
Conclusions:
- Significant advancements in genetics, proteomics, and cell therapy offer new hope for heart failure treatment.
- Future directions point towards evidence-based, individualized diagnostic and therapeutic approaches for heart failure.
Keywords:
Heart failureRelated Concept Videos
Heart Failure IV: Classification and Diagnostic Evaluation
1.0K
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
1.0K
Heart Failure III: Clinical Manifestations
1.2K
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
1.2K
Heart Failure I: Introduction
1.7K
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.7K
Cardiomyopathy V: Interprofessional Care
753
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753
Pathophysiology of Heart Failure
4.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.8K
Heart Failure II: Pathophysiology
1.9K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.9K

